Isolation of Streptococcus pneumoniae biofilm mutants and their characterization during nasopharyngeal colonization.
Asymptomatic colonization of the nasopharynx by Streptococcus pneumoniae precedes pneumococcal disease, yet pneumococcal colonization factors remain poorly understood. Many bacterial infections involve biofilms which protect bacteria from host defenses and antibiotics. To gain insight into the genetics of biofilm formation by S. pneumoniae, we conducted an in vitro screen for biofilm-altered mutants with the serotype 4 clinical isolate TIGR4. In a first screen of 6,000 mariner transposon mutants, we repeatedly isolated biofilm-overproducing acapsular mutants, suggesting that the capsule was antagonistic to biofilm formation. Therefore, we screened 6,500 additional transposon mutants in an S. pneumoniae acapsular background. Following this approach, we isolated 69 insertions in 49 different genes. The collection of mutants includes genes encoding bona fide and putative choline binding proteins, adhesins, synthases of membrane and cell wall components, extracellular and cell wall proteases, efflux pumps, ABC and PTS transporters, and transcriptional regulators, as well as several conserved and novel hypothetical proteins. Interestingly, while four insertions mapped to rrgA, encoding a subunit of a recently described surface pilus, rrgB and rrgC (encoding the other two pilus subunits) mutants had no biofilm defects, implicating the RrgA adhesin but not the pilus structure per se in biofilm formation. To correlate our findings to the process of colonization, we transferred a set of 29 mutations into the wild-type encapsulated strain and then tested the fitness of the mutants in vivo. Strikingly, we found that 23 of these mutants were impaired for nasopharyngeal colonization, thus establishing a link between biofilm formation and colonization.
Muñoz-Elías
Ernesto J
EJ
Howard Hughes Medical Institute and Department of Molecular Biology and Microbiology, Tufts University, Boston, MA 02115, USA.
Marcano
Joan
J
Camilli
Andrew
A
D018829:Adhesins, Bacterial / Q000235:genetics / Q000378:metabolism; D000818:Animals; D016667:Bacterial Capsules / Q000737:chemistry / Q000378:metabolism; D018441:Biofilms; D005260:Female; D005798:Genes, Bacterial; D051379:Mice; D008810:Mice, Inbred C57BL; D009154:Mutation; D009305:Nasopharynx / Q000382:microbiology*; D011008:Pneumococcal Infections / Q000235:genetics*; D016133:Polymerase Chain Reaction; D013296:Streptococcus pneumoniae / Q000302:isolation & purification* / Q000502:physiology*
D018829:Adhesins, Bacterial
J Infect Dis. 1998 Feb;177(2):368-77
9466523
J Antimicrob Chemother. 1997 Oct;40(4):601-2
9372435
Nat Rev Microbiol. 2008 Apr;6(4):288-301
18340341
J Bacteriol. 2003 Jan;185(2):413-21
12511486
Microb Pathog. 1997 Sep;23(3):127-37
9281471
J Med Microbiol. 2006 Apr;55(Pt 4):355-363
16533981
Nucleic Acids Res. 1992 Nov 25;20(22):6103
1461744
J Bacteriol. 2006 Apr;188(7):2325-35
16547018
J Bacteriol. 2006 Aug;188(16):5945-57
16885463
Lancet Infect Dis. 2004 Mar;4(3):144-54
14998500
Mol Microbiol. 1998 May;28(3):449-61
9632250
J Bacteriol. 2008 Apr;190(8):2767-76
18156255
JAMA. 2006 Jul 12;296(2):202-11
16835426
Infect Immun. 2005 Aug;73(8):4653-67
16040978
Mol Microbiol. 2001 Dec;42(5):1223-32
11886554
Science. 2001 Jul 20;293(5529):498-506
11463916
Microbiology (Reading). 2007 Dec;153(Pt 12):4088-4097
18048922
J Bacteriol. 2000 May;182(10):2675-9
10781532
EMBO J. 1996 Oct 1;15(19):5470-9
8895590
J Bacteriol. 2008 Jan;190(1):221-30
17981977
Nat Rev Microbiol. 2003 Dec;1(3):219-30
15035026
Mol Microbiol. 1997 Sep;25(5):819-29
9364908
Infect Immun. 2006 Apr;74(4):2453-6
16552078
J Biol Chem. 2002 Jul 19;277(29):26652-61
11953442
J Bacteriol. 2004 Mar;186(5):1249-57
14973035
Trends Microbiol. 2005 Jan;13(1):27-33
15639629
J Antimicrob Chemother. 1986 Jul;18 Suppl A:35-45
3745031
Mol Microbiol. 2005 Sep;57(6):1545-56
16135223
Mol Microbiol. 2002 Sep;45(5):1389-406
12207705
Microbes Infect. 2006 Jan;8(1):145-53
16182588
Science. 1998 Apr 10;280(5361):295-8
9535661
J Exp Med. 1931 Mar 31;53(4):535-52
19869863
Mol Microbiol. 2007 Jun;64(6):1455-65
17504273
Mol Microbiol. 2003 Nov;50(4):1103-10
14622402
Infect Immun. 2003 May;71(5):2758-65
12704150
J Bacteriol. 2007 Nov;189(22):8270-6
17586629
J Dent Res. 1998 Mar;77(3):445-52
9496917
J Bacteriol. 2006 Sep;188(18):6680-7
16952960
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D257-60
16381859
Infect Immun. 2001 Sep;69(9):5430-9
11500414
Trends Microbiol. 2005 Jan;13(1):20-6
15639628
Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2857-62
16481624
FEMS Microbiol Lett. 2008 Jan;278(2):231-5
18053067
J Bacteriol. 2007 May;189(9):3369-81
17322316
Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8927-32
9671781
Infect Immun. 2004 Jul;72(7):3902-6
15213133
J Bacteriol. 2006 Nov;188(22):7785-95
16936041
Infect Immun. 2001 Jun;69(6):3755-61
11349040
Infect Immun. 2007 Jan;75(1):83-90
17088346
Annu Rev Microbiol. 2000;54:49-79
11018124
Infect Immun. 2005 Feb;73(2):730-40
15664911
Infect Immun. 2001 Apr;69(4):2309-17
11254588
Infect Immun. 1994 Jun;62(6):2582-9
8188381
Infect Immun. 2007 Feb;75(2):958-65
17130253
J Bacteriol. 2005 Sep;187(17):6238-41
16109966
J Bacteriol. 2000 Mar;182(5):1374-82
10671461
Infect Immun. 2005 Oct;73(10):6945-51
16177374
Infect Immun. 1979 Feb;23(2):545-8
33904
J Clin Invest. 2003 Dec;112(11):1626-32
14660736
Infect Immun. 2004 Aug;72(8):4888-90
15271955
Infect Immun. 2000 Oct;68(10):5690-5
10992472
J Clin Invest. 2006 Aug;116(8):2297-2305
16862214
JAMA. 2002 Apr 3;287(13):1710-5
11926896
Infect Immun. 2003 Jan;71(1):218-25
12496169
Trends Microbiol. 2005 Jan;13(1):34-40
15639630
J Exp Med. 2002 Feb 4;195(3):359-65
11828011
Infect Immun. 2007 Jan;75(1):350-7
17088353
FEMS Microbiol Lett. 2005 Dec 1;253(1):151-4
16246506
Mol Microbiol. 2006 Sep;61(5):1196-210
16925554
Science. 2003 Jul 4;301(5629):105-7
12843396
J Bacteriol. 2008 Feb;190(4):1436-46
18065546
J Bacteriol. 2007 Mar;189(5):2030-8
17189375
Mol Microbiol. 2000 Jan;35(2):251-9
10652087
Mol Microbiol. 2007 Oct;66(2):329-40
17850254
Antimicrob Agents Chemother. 2001 Jun;45(6):1761-70
11353623
Infect Immun. 2006 Jul;74(7):4014-20
16790774
Cell Microbiol. 2007 Jul;9(7):1822-33
17359232
Mol Microbiol. 2007 May;64(4):968-83
17501921
Mol Microbiol. 2002 Mar;43(6):1367-78
11952892
Mol Microbiol. 1996 Jul;21(1):21-31
8843431
J Infect Dis. 1997 Apr;175(4):839-46
9086139
Vaccine. 2004 Jun 2;22(17-18):2209-20
15149779
J Clin Microbiol. 2007 Jan;45(1):97-101
17093036
Science. 1999 May 21;284(5418):1318-22
10334980
J Infect Dis. 1980 Dec;142(6):923-33
7462701
Nature. 2001 Oct 25;413(6858):860-4
11677611
J Bacteriol. 2005 Nov;187(21):7425-33
16237026
Infect Immun. 2005 Dec;73(12):8298-305
16299327
Res Microbiol. 2006 May;157(4):306-14
16487683
Appl Environ Microbiol. 2004 Aug;70(8):4980-8
15294838
J Bacteriol. 2005 Dec;187(24):8340-9
16321938